EXICURE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5001 USD | -1.75% |
|
-10.86% | -13.82% |
| 03-22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
| 02-29 | An unknown buyer agreed to acquire 39.3% stake in Exicure, Inc. from DGP Co.,Ltd. for KRW 6 billion. | CI |
Chart calendar Exicure, Inc.
b26ff2dbe.qF_adie6oU-SULG-SwctHXkKEpzGNfSEe0CBl2hR9yw.5hiSHUbw8H7DaeGTAn9bcTVSI_-ScrXIGAnZ-gk6umT6brweQsDKGNkU3g~c50b3262a61b834fb7d9783e3a483a46
Upcoming events on Exicure, Inc.
Past events on Exicure, Inc.
| 11/08/2023 21:01 | Q2 2023 Earnings Release |
| 14/07/2023 21:01 | Q1 2023 Earnings Release |
| 27/03/2023 21:01 | Q4 2022 Earnings Release |
| 14/12/2022 | Special Meeting |
| 14/11/2022 21:01 | Q3 2022 Earnings Release |
| 03/10/2022 21:00 | Chardan Genetic Medicines Conference |
| 15/08/2022 21:01 | Interim 2022 Earnings Release |
| 27/05/2022 19:00 | Annual General Meeting |
| 24/05/2022 12:00 | H.C. Wainwright Global Life Sciences Investment Conference |
| 16/05/2022 21:01 | Q1 2022 Earnings Release |
| 08/05/2022 | TIDES USA Oligonucleotide & Peptide Therapeutics Conference |
| 25/03/2022 20:15 | FY 2021 Earnings Release |
| 19/11/2021 12:00 | Q3 2021 Earnings Release |
| 16/11/2021 07:45 | SEMICON Europa Conference |
| 07/11/2021 | Society for Neuroscience Conference - Lauren Moore |
| 18/10/2021 14:55 | International OligonucIeotides and Peptides Conference |
| 08/10/2021 22:50 | International Congress on Neuronal Ceroid Lipofuscinosis Conference |
| 08/10/2021 22:50 | International Congress on Neuronal Ceroid Lipofuscinosis |
| 05/10/2021 16:00 | Chardan Virtual Genetic Medicines Conference |
| 30/09/2021 20:20 | Benzinga Healthcare Small Cap Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,12 0,11 5.36% | 1,30 1,07 21.35% | 16,6 19,0 -12.36% | -0,48 0,90 -153.67% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -21,8 -23,1 5.66% | -26,6 -23,2 -14.58% | -25,4 -22,2 -14.57% | 0,00 0,00 - |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,4 -23,8 5.97% | -26,3 -23,1 -13.8% | -24,7 -21,2 -16.55% | 0,00 0,00 - |
|
Net income Million USD | Released Forecast Spread | -22,4 -23,8 5.97% | -26,3 -23,1 -13.8% | -24,7 -22,3 -10.58% | 0,00 0,00 - |
|
EPS USD | Released Forecast Spread | -16,2 -17,7 8.47% | -13,8 -12,3 -12.2% | -8,40 -7,65 -9.8% | -21,6 -21,3 -1.41% |
| Announcement Date | 08/03/19 | 03/03/20 | 11/03/21 | 25/03/22 |
Quarterly results
| Fiscal Period | December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,08 1,55 -94.91% | -3,68 6,99 -152.62% | 2,12 3,50 -39.49% | 2,57 4,30 -40.35% | 2,47 4,30 -42.53% |
|
EBIT Million USD | Released Forecast Spread | -13,9 -12,6 -10.01% | -23,1 -7,34 -214.6% | |||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,3 -12,7 -12.64% | -23,5 -7,58 -210.33% | |||
|
Net income Million USD | Released Forecast Spread | -14,3 -12,8 -11.87% | -23,5 -7,58 -210.33% | |||
|
EPS USD | Released Forecast Spread | -4,80 -4,20 -14.29% | -8,10 -2,85 -184.21% | -4,50 -4,20 -7.14% | -2,10 -2,10 0% | -1,66 -1,20 -38.33% |
| Announcement Date | 12/08/21 | 19/11/21 | 25/03/22 | 16/05/22 | 15/08/22 |
More events
Past sector events for Exicure, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- XCUR Stock
- Calendar Exicure, Inc.
